GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » HeartSciences Inc (NAS:HSCS) » Definitions » Total Assets

HSCS (HeartSciences) Total Assets : $5.70 Mil (As of Jan. 2025)


View and export this data going back to 2022. Start your Free Trial

What is HeartSciences Total Assets?

HeartSciences's Total Assets for the quarter that ended in Jan. 2025 was $5.70 Mil.

During the past 12 months, HeartSciences's average Total Assets Growth Rate was -16.60% per year. During the past 3 years, the average Total Assets Growth Rate was 45.30% per year.

During the past 5 years, HeartSciences's highest 3-Year average Total Assets Growth Rate was 45.30%. The lowest was 3.70%. And the median was 24.50%.

Total Assets is connected with ROA %. HeartSciences's annualized ROA % for the quarter that ended in Jan. 2025 was -150.49%. Total Assets is also linked to Revenue through Asset Turnover. HeartSciences's Asset Turnover for the quarter that ended in Jan. 2025 was 0.00.


HeartSciences Total Assets Historical Data

The historical data trend for HeartSciences's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HeartSciences Total Assets Chart

HeartSciences Annual Data
Trend Apr20 Apr21 Apr22 Apr23 Apr24
Total Assets
1.96 1.93 2.09 3.29 9.50

HeartSciences Quarterly Data
Apr20 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.80 9.50 8.19 7.78 5.70

HeartSciences Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

HeartSciences's Total Assets for the fiscal year that ended in Apr. 2024 is calculated as

Total Assets=Total Equity (A: Apr. 2024 )+Total Liabilities (A: Apr. 2024 )
=7.317+2.186
=9.50

HeartSciences's Total Assets for the quarter that ended in Jan. 2025 is calculated as

Total Assets=Total Equity (Q: Jan. 2025 )+Total Liabilities (Q: Jan. 2025 )
=1.787+3.917
=5.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HeartSciences  (NAS:HSCS) Total Assets Explanation

Total Assets is connected with ROA %.

HeartSciences's annualized ROA % for the quarter that ended in Jan. 2025 is

ROA %=Net Income (Q: Jan. 2025 )/( (Total Assets (Q: Oct. 2024 )+Total Assets (Q: Jan. 2025 ))/ count )
=-10.144/( (7.777+5.704)/ 2 )
=-10.144/6.7405
=-150.49 %

Note: The Net Income data used here is four times the quarterly (Jan. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

HeartSciences's Asset Turnover for the quarter that ended in Jan. 2025 is

Asset Turnover
=Revenue (Q: Jan. 2025 )/( (Total Assets (Q: Oct. 2024 )+Total Assets (Q: Jan. 2025 ))/ count )
=0/( (7.777+5.704)/ 2 )
=0/6.7405
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

HeartSciences Total Assets Related Terms

Thank you for viewing the detailed overview of HeartSciences's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


HeartSciences Business Description

Traded in Other Exchanges
N/A
Address
550 Reserve Street, Suite 360, Southlake, TX, USA, 76092
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
Executives
David R. Wells director 2801 OCEAN PARK BLVD., SUITE 339, SANTA MONICA CA 90405
Bruce Bent director 750 BONHAM PARKWAY, LANTANA TX 76226
Mark T Hilz director, officer: See Remarks 3301 DAKOTA DRIVE, NORTHLAKE TX 76226
Patrick Kanouff director 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Brian Szymczak director 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Danielle Watson officer: See Remarks 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Andrew Simpson director, officer: See Remarks 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092